Suber S. Huang, MD, MBA, will serve as Digital's Medical Director for
Ophthalmology
WAKE FOREST, N.C., Nov. 15 /PRNewswire/ -- Digital Healthcare, a Wake Forest, NC company specializing in retinal risk assessment for diabetics, announced today that Suber S. Huang, MD, MBA has been named Medical Director for Ophthalmology. Dr. Huang will provide the company expert advice and counsel regarding product development and development.
Dr. Huang is the Philip F. and Elizabeth G. Searle-Suber Huang, MD, Professor and Vice Chairman in the Department of Ophthalmology and Visual Sciences, University Hospitals Case Medical Center, Cleveland, Ohio. He is the Director of Vitreoretinal Diseases and Surgery, the Director of Clinical Research, and the Director of the Retinal Diseases Image Analysis Reading Center (REDIARC). Dr. Huang serves on the Executive Board of Directors for the American Society of Retina Specialists, the world's largest organization of retinal specialists. Dr. Huang is the Director of the Diabetic Eye Disease Committee of the National Eye Health Education Program and the serves on the Ophthalmic Technology Assessment Committee (OTAC)-Retina/Vitreous Panel and on the Research, Regulatory, and External Scientific Relations Committee, both committees associated with the American Academy of Ophthalmology.
"Having one of the country's premier retinal specialists on our team will be invaluable," said Marc Winchester, President, North America and Board Director of Digital Healthcare. "Retasure is focused on retinal health and, we will rely on Dr. Huang's vast medical expertise to advise us on future product enhancements. With Dr. Huang's input, Retasure will continue to be the industry's leading retinal risk assessment tool."
"Retasure is a terrific system that provides benefits for patients at
risk for diabetic retinopathy," said Dr. Huang. "Earlier detection of
patients with diabetic eye disease by endo
'/>"/>
| SOURCE Digital Healthcare Inc. Copyright©2007 PR Newswire. All rights reserved |